Patient's question:
Morphological examination report: Thrombocytopenia, very active bone marrow hyperplasia, granular system 50.5%, erythroid system 37%, granulocyte to erythrocyte ratio 1.36:1; granular system fibrosis, proportions and morphology of all stages are approximately normal; erythroid system fibrosis, proportions slightly increasing, based on medium and late-stage erythroblasts, morphology normal; lymphocyte proportion relatively increased; a total of 124 megakaryocytes were observed in the entire section, classified as 25, mature with platelets 0, mature without platelets 22, naked nuclei 1, immature without granules 2, platelets rarely seen. Opinion: Fibrosis of granulocytes, erythrocytes, and megakaryocytes; megakaryocytes continuously increasing, poor platelet production, suggesting changes in bone marrow morphology due to thrombocytopenia. What could have caused this situation, and what should be paid attention to?Doctor's answer:
Primary thrombocytopenic purpura is an immune-related syndrome. The acute form often recurs after recovery from acute viral upper respiratory tract infections. In chronic cases, more than half of the patients can be detected with antiplatelet antibodies in the serum. Factors such as cellular immune dysfunction, splenic factors, and higher estrogen levels can all lead to thrombocytopenia. The acute form is typically self-limiting, with more than 80% resolving on their own within an average course of 4 to 6 weeks. In very rare cases, it may develop into or transition to a chronic form over several years. Medications such as inosine, amino acid peptides, and nucleotides can be used to raise platelet counts. For skin bleeding, hemostatic drugs are applied. Additionally, corticosteroids, immunosuppressants, and immunoglobulins may be used for treatment. In some cases, splenectomy may be necessary.